Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.12 (
biotinidase
)
392
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Biotinidase activities found in porcine brains (n = 3) were as follows: cerebrum, 4.4 +/- 0.2 pmol/min per milligram of protein; cerebellum, 7.6 +/- 0.3 pmol/min per milligram of protein; medulla, 2.9 +/- 0.3 pmol/min per milligram of protein. These values are relatively high compared with the activities in rat or guinea pig brains. Subcellular distribution of
biotinidase
was found mainly in the soluble cytoplasmic fraction (S3), i.e., in the supernatant of 0.32 M sucrose S2 solution after ultracentrifugation at 105,000g for 90 min. This is in contrast to the guinea pig livers, in which the subcellular distribution of
biotinidase
is mainly found in the
microsomal
fraction. After a seven-step purification (22,200-fold enrichment), porcine brain
biotinidase
is identified as a single polypeptide by the sodium dodecyl sulfate-polyacrylamide gel electrophoresis system, and its molecular weight is determined as 68,000 Da. The isoelectric point of the enzyme was 4.3. Sialidase treatment strongly suggests the presence of sialyl residues in this enzyme. Amino acid analysis indicates relatively high hydrophilicity and high content of glycine and serine. The enzyme activity is inhibited by organic mercurials, but not by diisopropylfluorophosphate. Abundant soluble
biotinidase
in brain cytoplasm may play an important role which has not been discovered yet.
...
PMID:Biotinidase in the porcine cerebrum. 232 94
Guinea pig
biotinidase
and lipoamidase were mostly located in the liver
microsomal
fraction. Approx. 80% of the total activities of both enzymes were associated with the membranes subfractions of liver. The subunit molecular masses of these enzymes as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of
microsomal
biotinidase
and lipoamidase were 70 and 60 kDa, respectively. Sephadex G-200 gel-permeation chromatography in the presence of 0.1% Nonidet P-40 indicated that the native-state molecular masses of
microsomal
biotinidase
and lipoamidase were 68 and 120 kDa, respectively. The isoelectric points of
microsomal
biotinidase
and lipoamidase were 6.3 and 5.7, respectively. Linear sucrose density centrifugation analysis indicated that both enzymes exist in the rough endoplasmic reticulum. Comparison of amino acid analyses indicated a higher content of leucine and lower content of serine in lipoamidase than in
biotinidase
. Microsomal
biotinidase
and lipoamidase were classified as being thiol-type and serine-type amidases, respectively.
...
PMID:Biotinidase and lipoamidase in guinea pig livers. 273 Sep 18
Biotin-binding immunoglobulin (BBI) was recently identified in human serum and has been suggested to have a significant association with allergic and autoimmune disorders. Attempts were made to evaluate the clinical significance of BBI in autoimmune thyroid disorders. Prevalence of BBI was significantly higher in Graves' disease (47%) than in Hashimoto's disease (8%) and healthy controls (10%). The BBI consisted of heterogeneous subtypes with respect to binding of several immunoglobulin classes. Sera in Graves' disease showed predominantly IgG-binding BBI, whereas healthy subjects had IgM-binding BBI. Thyroid stimulating hormone receptor antibody (TRAb) level was significantly higher in the BBI non-detected group than in the detected group. There was no significant relationship between BBI prevalence and thyroid hormone concentrations, anti-thyroglobulin antibody (TGAb) or anti-thyroid
microsomal
antibody (McAb) titers. In addition, biotin levels in peripheral blood and red blood cells and
biotinidase
activity did not differ in the BBI detected and non-detected groups. The present results suggest that BBI is associated with autoimmune dysfunction in Graves' disease.
...
PMID:Clinical evaluation of biotin-binding immunoglobulin in patients with Graves' disease. 791 19
Lipoamidase (not yet given an EC number) activity was measured in various rat tissues using two different substrates, one natural, lipoyllysine (epsilon-N-(D,L-lipoyl)L-lysine) and one artificial, lipoyl-p-aminobenzoic acid (N-D,L-lipoyl-p-aminobenzoic acid). Biotinidase,
EC 3.5.1.12
, was measured in the same tissue with the artificial substrate, biotinyl-p-aminobenzoic acid (N-D-biotinyl-p-aminobenzoic acid). Lipoamidase measured as lipoyl-p-aminobenzoic acid hydrolase activity had two pH optima, at pH 6.0 and pH 9.5, in liver homogenate, but only one pH optimum at pH 6.0 in rat plasma. Lipoamidase measured as lipoyllysine hydrolase activity had a pH optimum at pH 5.5 both in liver homogenate and plasma. Similarly,
biotinidase
shows a single pH optimum at pH 6.0 in liver homogenate and plasma. The properties of lipoyllysine hydrolase and
biotinidase
were similar with respect to thermostability, pH stability and inhibition pattern, and their properties differed from those of lipoyl-p-aminobenzoic acid hydrolase. Lipoyllysine hydrolase and
biotinidase
activities were highest in kidney, liver and blood plasma, whereas lipoyl-p-aminobenzoic acid hydrolase activities were highest in liver, brain and kidney. Lipoyllysine hydrolase and
biotinidase
activities were found mainly in the liver
microsomal
fraction, and lipoyl-p-aminobenzoic acid hydrolase was recovered from the
microsomal
fraction and to a small extent from the mitochondrial fraction. These results indicate that liver lipoyl-p-aminobenzoic acid hydrolase is an enzyme protein which differs from lipoyllysine hydrolase, and the data also indicate that liver lipoyllysine hydrolase and
biotinidase
are the same enzyme protein.
...
PMID:Lipoamidase and biotinidase activities in the rat: tissue distribution and intracellular localization. 798 29
Biotinidases from various species ranging from fungi and insects to human have specific amino acids, and regions that are evolutionarily conserved. These specific amino acids and regions are further supported by their homology to a variety of amidases and nitrilases and by the location of missense mutations that cause
biotinidase
deficiency in humans. Glu-Lys-Cys residues from three of these regions are considered the catalytic triad involved in the catalysis of the amide linkage. The last one-third of the
biotinidase
sequence is lacking in nitrilases-amidases, which do not bind biocytin or biotin, therefore, it is likely that the biocytin-biotin-binding site of
biotinidase
is within this portion of the molecule. Although there are many missense mutations at the far C-terminus of the enzyme, the function of this region is still unclear. Biotinidase may have different functions in different cells or in different subcellular compartments. Using computer programs that predict the subcellular localization of proteins based on their N-terminal signal peptides,
microsomal
localization resulting in secretion was predicted for
biotinidase
from all species, whereas there is little consistent support for mitochondrial or nuclear localization of the enzymes. Additional immunohistochemical studies of various human tissues at different stages of development are necessary to resolve the ambiguity of subcellular localization of
biotinidase
.
...
PMID:Evolutionary conservation of biotinidase: implications for the enzyme's structure and subcellular localization. 1615 Jun 25